Interventional Study Exploring the Occurrence of Surgical Site Infections.
Completed · Not applicable · NCT06661473
Conditions: Total Knee Arthroplasty, Total Hip Arthroplasty Revision, Total Knee Arthroplasty Revision
At a glance
- Research payments reported, 2025
- $308,308
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 104
About the trial
- Sponsor
- Molnlycke Health Care AB
- Tested
- Avance Solo Negative Pressure Wound Therapy (device)
- Dates
- Started 2024-10-03; completion 2025-12-23
- Results posted
- Not yet
Interventional study exploring surgical site complication occurrences in high-risk revision patients undergoing TKA or THA using NPWT.
From ClinicalTrials.gov, last updated 2026-03-31. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Molnlycke Health Care Ab reported $308,308 in research payments for this study in 2025 (5 payments).
Products named: Avance Solo
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Philip S. Huang, DO Orthopedic Surgery · Carmel, IN
- Scott D. Anseth, M.D. Orthopedic Surgery · Edina, MN
- Jeffrey B. Whiting, M.D. Orthopedic Surgery · Saint Louis, MO
- John V. Gentile, DO Orthopedic Surgery · Youngstown, OH
- David F. Scott, M.D. Joint Replacement Surgery · Spokane, WA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- St Louis University $125,955
- Twin Cities Orthopedics $65,590
- Mh St Elizabeth Youngstown Hospital, OH $59,163
- Spokane Joint Replacement Center $29,176
- The Orthopaedic Research Foundation $28,425
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.